Palatin Technologies is a biopharmaceutical company engaged in the development of targeted, receptor-specific peptide therapeutics for treating diseases that have significant unmet medical need but where there is also commercial potential. The company’s strategy involves developing products and then forming marketing collaborations with industry leaders to maximize the products’ commercial potential. For more information, visit the company’s Web site at www.palatin.com.

The BIO CEO & Investor Conference is the largest investor conference focused on established and emerging publicly traded biotech companies. Each year the annual event provides a neutral forum where institutional investors, industry analysts, and senior biotechnology executives have the opportunity to shape the future investment landscape of the biotechnology industry. For more information on Biotechnology Industry Organization (BIO), visit www.bio.org.

Let us hear your thoughts below: